Key Takeaways
- Steady demand, AI acceleration: The demand environment remained largely unchanged, with clients focused on efficiency and AI adoption, while BFSI and Tech sectors showed the strongest momentum.
- Bookings slipped, not lost: TCV was soft as two confirmed deals missed the quarter on paperwork delays; both are expected to sign in Q3, and the pipeline is described as very robust.
- Margins inch up, investment continues: Operating margin expanded 0.5% sequentially to 16.5% on operational improvements and rupee depreciation, offset by continued AI investments that management will not pull back.
- Headcount drops on AI productivity: A reduction of 6,500-plus people reflected no campus hiring in H1 and productivity gains from AI projects; campus hiring resumes in H2.
- What to watch next quarter: Whether the two slipped deals close and convert to Q4 revenue upside, the pace of margin recovery toward the 17–17.5% band, and any stabilization in US healthcare.
Demand Environment
- Broadly unchanged: Clients remain focused on efficiency, productivity, and accelerating AI adoption, with no material shift in the demand backdrop from prior quarters.
- BFSI momentum: Strong, driven by cost optimization, legacy modernization, and scaling agentic AI; a previously delayed mega deal is now ramping up, and a BFSI Europe customer that had moved work to captive is showing good momentum again.
- Tech sector strength: Digital native and new-age firms are driving demand; investments span custom silicon, design-to-manufacture, physical AI, and the full AI model ecosystem from training to execution.
- EMR traction: The sector had a good quarter with very strong traction, especially in energy, where growth has returned after taking some time.
- Consumer mixed: Good traction in CPG, travel, and transportation, with recent wins and Olam deal revenue supporting performance.
- Healthcare pressured: US healthcare continues to be affected by policy changes; large payers are tightening discretionary spend and prioritizing AI, automation, and compliance, though sustained cost pressures are creating new outsourcing opportunities from first-time outsourcers.
- Americas split: Americas 1 declined sequentially on client-specific issues and healthcare softness; Americas 2 grew, driven by EMR with encouraging BFSI momentum.
- Europe and APMEA: Europe posted broad-based growth led by BFSI, Consumer, and EMR; APMEA showed strong traction fueled by Consumer, Tech, and Comms.
- Client-specific issues receding: The client-specific issues highlighted in prior quarters are largely behind; Q3 should see the large part of it done.
Pallia: "This quarter, demand environment has remained largely unchanged. Our clients remain focused on efficiency and productivity, while increasingly looking to accelerate AI adoption and drive long-term value."
Deal Wins & Pipeline
- TCV shortfall: A few deals could not be signed on time due to paperwork delays and slipped to Q3; both deals are expected to be signed and are now in the process of closing.
- Pipeline strength: The Q3 pipeline is described as extremely strong and robust; management is optimistic of better closure in Q3, and deals that slipped from Q2 will be picked up.
- Bookings mix: Healthy mix of new business and expansion of existing engagements.
- Revenue conversion timing: Q3 deals, once closed, should give revenue upside in Q4; confidence in the Q4 outlook is expected to increase if deals close in the early half of Q3.
- Consulting-led BFSI win: A global financial institution engaged Wipro for an AI-enabled operating model transformation, covering software development modernization, efficiency, and scaled AI-powered ways of working.
- Mid-market consumer win: A global mid-market consumer products company selected Wipro to establish an AI capability center in India, scaling engineering and technology operations for ERP modernization, cloud-native platforms, and AI capabilities.
- Alpha Net acquisition: Described as a tuck-in within a large client for vendor consolidation; not material enough to call out separately.
Pallia: "We had confirmed orders in quarter 2. Unfortunately, some paperwork did not get signed. So those deals, we will pick it up in quarter 3. So, they're not going anywhere."
AI & the AI-Native Unit
- AI-native unit progress: Launched in April with over 2,000 engineers including Forward Deployed Engineers; seeing growing success in outcome-based deals.
- Production deployments: Examples include an SLM deployment for a major US retail bank, an AI-powered digital plant for a large Middle East petrochemical company, and an enrollment and billing SLM deployment for a leading US healthcare payer.
- Industry-specific SLMs: Built for wealth management, insurance, healthcare, aviation, and asset-intensive industries, combined with AI agents and an orchestration platform.
- Five emerging AI growth themes: Wipro is accelerating investments across AI data centers, AI foundry services, physical AI, AI devices, and design-to-manufacturing.
- AI-driven productivity: Productivity improvements from AI projects were cited as a factor in headcount trends, alongside no campus hiring in the first half.
- AI and pipeline: AI is helping in the context of pipeline generation and winning in the marketplace.
Pallia: "We will continue to make these investments even when they create near-term margin headwinds. They enhance our strategic position, expand addressable markets, and build a stronger foundation for future growth."
Vertical Performance
| Vertical | Trend | Commentary |
|---|---|---|
| BFSI | ▲ Growth | 1% sequential, 1.3% YoY; driven by consulting-led transformation deal, mega deal ramp-up, and recovering Europe customer. Capco performed well across APMEA, Continental Europe, and UK. Pipeline very strong. |
| Technology | ▲ Strong | Digital native and new-age firms driving demand; growth across AI model ecosystems, custom silicon, and design-to-manufacture. Expected to compete with BFSI for growth leadership. |
| EMR | ▲ Good traction | Strong quarter, especially in energy; growth has returned after taking time. Good wins in prior quarters now ramping up. |
| Consumer | ▬ Mixed | Good traction in CPG, travel, and transportation; recent wins and Olam deal supported performance. |
| Healthcare | ▼ Weak | US healthcare affected by policy changes; large payers tightening discretionary spend. First-time outsourcers emerging due to cost pressures. Q3 seasonality expected to help, though less than prior years. |
| Americas 1 | ▼ Declined | Client-specific issues and healthcare softness drove sequential decline; issues largely behind, with Q3 expected to see most of it resolved. |
| Americas 2 | ▲ Growth | Driven by EMR with encouraging BFSI momentum. |
| Europe | ▲ Broad-based | Growth led by BFSI, Consumer, and EMR. |
| APMEA | ▲ Strong traction | Fueled by Consumer, Tech, and Comms. |
Pallia: "I'll let my team compete. It is between BFSI and Tech."
Margins & Financials
- Operating margin: Expanded 0.5% sequentially to 16.5%, driven by operational improvements and rupee depreciation, offset by continuing investments in the business.
- Net other income: Declined 68% sequentially because investable surplus reduced QoQ following completion of the buyback in June 2026.
- Net income: Declined 5% sequentially as a result of lower other income.
- EPS: Increased 0.9% sequentially and 4.2% YoY, noted as the right metric given completion of the buyback.
- Investment posture: Management will continue AI investments even when they create near-term margin headwinds; the endeavor is to continuously improve margins from current levels while creating headspace for growth.
- Margin ambition: Would like to get back to the 17–17.5% band as quickly as possible, but no timeline is being put out.
- Wage hikes: Salary increases effective 1st March 2026 were given; not under consideration for another at this time.
- Deflationary cycle: Average contract tenor is 2–2.5 years; the cycle has been ongoing for 1.5–2 years, so many contracts have been refreshed. Management expects to be at the inflection curve in a few quarters.
Iyer: "We would like to get back to the band as quickly as possible, but we're not putting a timeline out there."
People & Headcount
- Headcount reduction: Q2 reduction attributed to no campus hiring in the first half and productivity improvements from AI projects.
- Campus hiring: No campus hiring conducted in H1; plans to go to campuses in the second half given volume growth, and headcount should even out.
- AI-native unit staffing: Over 2,000 engineers including Forward Deployed Engineers now in the unit launched in April.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Q3 revenue growth | IT services revenue growth of minus 1.5% to plus 0.5% in constant currency, impacted by seasonal furloughs | Q3 FY27 |
| Slipped deal closure | Two deals that missed Q2 on paperwork are in the process of being signed; confident of securing both | Q3 FY27 (update promised in January) |
| Campus hiring resumption | Campus hiring to resume given volume growth; headcount should even out | H2 FY27 |
| Margin improvement | Endeavor to continuously improve margins from current levels, aiming for 17–17.5% band | No timeline given |
| Deflationary cycle inflection | Expect to be at the inflection curve after many contracts have been refreshed | "In a few quarters" |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| IT services revenue | $2.61 billion, flat sequentially and up 0.6% YoY in constant currency |
| Operating margin | 16.5%, an improvement of 0.5% sequentially; operational improvements and rupee depreciation offset by continuing investments |
| Net income | ₹3,200 crore, declined 5% sequentially due to lower other income from reduced investable surplus post-buyback |
| EPS | ₹3.23, increased 0.9% sequentially and 4.2% YoY |
| Q3 FY27 revenue guidance | -$1.5% to +0.5% sequential in constant currency, translating to $2.571 billion to $2.625 billion |
| Total contract value (TCV) | $2.6 billion, with nine large deals signed; two additional deals slipped to Q3 due to paperwork delays |
| Operating cash flow | 166% of net income |
| Gross cash | ₹460 crore as of 30th September |
| Effective tax rate | 23.9%, flattish compared to same quarter last year |
| Net other income | Declined 68% sequentially, primarily due to reduced investable surplus after completion of buyback in June 2026 |
| Headcount | Reduced by 6,500-plus sequentially; year-on-year flattish with no campus hiring in first half |
| AI native unit engineers | Over 2,000, including forward deployed engineers |
| BFSI revenue growth | 1% sequentially and 1.3% YoY in constant currency |
| Consumer revenue growth | 2.6% sequentially and 6% YoY in constant currency |
| Health revenue growth | Declined 3.8% sequentially and 6.5% YoY in constant currency, impacted by US policy changes |